Opinion

Why Childhood Cancer should stay high on the EU agenda for 2024–2029 – SIOP Europe

Photo from SIOP Europe/LinkedIn

Sep 30, 2024, 08:29

Why Childhood Cancer should stay high on the EU agenda for 2024–2029 – SIOP Europe

SIOP Europe shared the following on LinkedIn:

“It has begun! Today we answer a very important question for our community: ‘Why Childhood Cancer should stay high on the EU agenda for 2024–2029?’

The insightful panel discussions and reflections unravel strategies on bridging the gaps between the inequalities in Europe and why this should be the focus for this new mandate.

Join us right now.”

Source: SIOP Europe/LinkedIn

cancer community Cancer research Childhood Cancer Childhood Cancer Advocacy EU agenda European Union health inequalities health policy OncoDaily Oncology patient care SIOP Europe

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage